Targeting a binding pocket within the trimer-of-hairpins: Small-molecule inhibition of viral fusion

被引:87
作者
Cianci, C
Langley, DR
Dischino, DD
Sun, YX
Yu, KL
Stanley, A
Roach, J
Li, ZF
Dalterio, R
Colonno, R
Meanwell, NA
Krystal, M
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Wallingford, CT 06492 USA
[2] Milton S Hershey Med Ctr, Hershey, PA 17033 USA
关键词
D O I
10.1073/pnas.0406696101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Trimeric class 1 virus fusion proteins undergo a series of conformational rearrangements that leads to the association of C- and N-terminal heptad repeat domains in a "trimer-of-hairpins" structure, facilitating the apposition of viral and cellular membranes during fusion. This final fusion hairpin structure is sustained by protein-protein interactions, associations thought initially to be refractory to small-molecule inhibition because of the large surface area involved. By using a photoaffinity analog of a potent respiratory syncytial virus fusion inhibitor, we directly probed the interaction of the inhibitor with its fusion protein target. Studies have shown that these inhibitors bind within a hydrophobic cavity formed on the surface of the N-terminal heptad-repeat trimer. In the fusogenic state, this pocket is occupied by key amino acid residues from the C-terminal heptad repeat that stabilize the trimer-of-hairpins structure. The results indicate that a low-molecular-weight fusion inhibitor can interfere with the formation or consolidation of key structures within the hairpin moiety that are essential for membrane fusion. Because analogous cavities are present in many class 1 viruses, including HIV, these results demonstrate the feasibility of this approach as a strategy for drug discovery.
引用
收藏
页码:15046 / 15051
页数:6
相关论文
共 49 条
[1]  
Aulabaugh Ann, 2000, Drugs of the Future, V25, P287, DOI 10.1358/dof.2000.025.03.572014
[2]   INHIBITION OF THE FUSION-INDUCING CONFORMATIONAL CHANGE OF INFLUENZA HEMAGGLUTININ BY BENZOQUINONES AND HYDROQUINONES [J].
BODIAN, DL ;
YAMASAKI, RB ;
BUSWELL, RL ;
STEARNS, JF ;
WHITE, JM ;
KUNTZ, ID .
BIOCHEMISTRY, 1993, 32 (12) :2967-2978
[3]   CHARMM - A PROGRAM FOR MACROMOLECULAR ENERGY, MINIMIZATION, AND DYNAMICS CALCULATIONS [J].
BROOKS, BR ;
BRUCCOLERI, RE ;
OLAFSON, BD ;
STATES, DJ ;
SWAMINATHAN, S ;
KARPLUS, M .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1983, 4 (02) :187-217
[4]   SEQUENCE-ANALYSIS OF THE GENE ENCODING THE FUSION GLYCOPROTEIN OF PNEUMONIA VIRUS OF MICE SUGGESTS POSSIBLE CONSERVED SECONDARY STRUCTURE ELEMENTS IN PARAMYXOVIRUS FUSION GLYCOPROTEINS [J].
CHAMBERS, P ;
PRINGLE, CR ;
EASTON, AJ .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :1717-1724
[5]   Core structure of gp41 from the HIV envelope glycoprotein [J].
Chan, DC ;
Fass, D ;
Berger, JM ;
Kim, PS .
CELL, 1997, 89 (02) :263-273
[6]   Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target [J].
Chan, DC ;
Chutkowski, CT ;
Kim, PS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15613-15617
[7]   The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion [J].
Chen, L ;
Gorman, JJ ;
McKimm-Breschkin, J ;
Lawrence, LJ ;
Tulloch, PA ;
Smith, BJ ;
Colman, PM ;
Lawrence, MC .
STRUCTURE, 2001, 9 (03) :255-266
[8]   pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion [J].
Cianci, C ;
Yu, KL ;
Dischino, DD ;
Harte, W ;
Deshpande, M ;
Luo, GX ;
Colonno, RJ ;
Meanwell, NA ;
Krystal, M .
JOURNAL OF VIROLOGY, 1999, 73 (03) :1785-1794
[9]   Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection [J].
Cianci, C ;
Genovesi, EV ;
Lamb, L ;
Medina, I ;
Yang, Z ;
Zadjura, L ;
Yang, H ;
D'Arienzo, C ;
Sin, N ;
Yu, KL ;
Combrink, K ;
Li, ZF ;
Colonno, R ;
Meanwell, N ;
Clark, J ;
Krystal, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (07) :2448-2454
[10]   Orally active fusion inhibitor of respiratory syncytial virus [J].
Cianci, C ;
Yu, KL ;
Combrink, K ;
Sin, N ;
Pearce, B ;
Wang, A ;
Civiello, R ;
Voss, S ;
Luo, GX ;
Kadow, K ;
Genovesi, EV ;
Venables, B ;
Gulgeze, H ;
Trehan, A ;
James, J ;
Lamb, L ;
Medina, I ;
Roach, J ;
Yang, Z ;
Zadjura, L ;
Colonno, R ;
Clark, J ;
Meanwell, N ;
Krystal, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :413-422